首页> 中国专利> 一种联合检测TORCH特异性抗体的酶免疫试剂盒

一种联合检测TORCH特异性抗体的酶免疫试剂盒

页面导航

摘要
著录项
法律信息
相似文献

摘要

本实用新型涉及一种用于医学上联合检测TORCH特异性抗体的酶免疫试剂盒，它能方便、快捷、精确地联合检测TORCH 5种病原体的特异性的抗体。本实用新型是由外框支撑架及放置于其上的可拆酶标反应板条组成，在每个可拆酶标反应板条上设置有反应孔，在反应孔中涂布有已知的抗体或抗原，其特征在于：在外框支撑架上放置有3条以上的可拆酶标反应板条，每个可拆酶标反应板条上排列有4～10个反应孔，在每个反应孔的内表面与已涂布的抗体或抗原之间涂布有一、二或数层膜。

著录项

公开/公告号CN2531391Y

专利类型
公开/公告日2003-01-15

原文格式PDF
申请/专利权人王滔;
展开▼

申请/专利号CN01252075.6
发明设计人王滔;
展开▼

申请日2001-09-30
分类号G01N33/53;G01N33/569;
代理机构
代理人
地址 350001 福建省福州市鼓楼区湖前路92号4-403
入库时间 2022-08-21 22:44:08

法律信息

法律状态公告日

法律状态信息

法律状态
2007-11-21

专利权的终止未缴年费专利权终止

专利权的终止未缴年费专利权终止
2003-01-15

授权

授权

相似文献

专利
中文文献
外文文献

1. 一种联合检测TORCH特异性抗体的酶免疫试剂盒 [P] . 中国专利： CN2531391Y . 2003-01-15
2. 一种检测H7N9亚型禽流感病毒神经氨酸酶特异性抗体的多肽-酶联免疫吸附试剂盒 [P] . 中国专利： CN105445459A . 2016-03-30
3. ? The antibody, peptide, nucleic acid molecule, vector, cell or animal not human, composition, kit, uses of an antibody, a peptide, a molecule, or a vector.Methods to determine whether cells expressing CD9 are present in a sample, to produce an antibody or a functional part or functional equivalent.To treat or prevent a disorder associated with the cells expressing CD9 and to produce a cell specific immune CD9 or an antibody specific for CD9,Ex vivo method to determine if a person is suffering from a cancer positive for CD9, immunogenic composition and diagnostic kit. [P] . BR112018013801A2 . 2018-12-11

机译：？抗体，肽，核酸分子，载体，非人类的细胞或动物，组合物，试剂盒，抗体，肽，分子或载体的用途确定样品中是否存在表达CD9的细胞的方法为了生产或预防与表达CD9的细胞有关的疾病并产生细胞特异性免疫CD9或CD9特异性抗体，体外方法来确定一个人是否患有疾病。 CD9阳性的癌症，免疫原性成分和诊断试剂盒。
4. Preparation of isolated protein, substantially pure or recombinant, isolated trt protein, substantially pure or recombinant isolated trt protein, substantially pure or recombinant, isolated trt protein or a variant thereof, or a fragment, polynucleotide, synthetic, substantially pure or recombinant, isolated nucleic acid, encoding a trt protein, expression vector, transfected cell, non-human animal, or its progeny, transgenic non-human animal, antibody or its binding fragment, antibody, specifically immunoreactive under immunologically reactive conditions, for a trt protein or its immunogenic fragment, processes of determining whether a compound or treatment is a modulator of a trt activity or expression, of determining whether a test compound is a modulator of a trt activity, of preparing recombinant telomerase, to detect a trt gene product in a sample, to detect the presence of d and at least one telomerase positive human cell in a biological sample comprising human cells, to diagnos [P] . BR9711844A . 2000-01-18

机译：分离的蛋白质，基本上纯的或重组的分离的trt蛋白，基本上纯的或重组的分离的trt蛋白，基本上纯的或重组的分离的trt蛋白或其变体或片段，多核苷酸，合成的，基本上纯的或重组的分离的核酸的制备编码trt蛋白的酸，表达载体，转染的细胞，非人类动物或其后代，转基因非人类动物，抗体或其结合片段，抗体，在免疫反应条件下对trt蛋白或其免疫原具有特异性片段，确定化合物或处理是否是trt活性或表达的调节剂，确定测试化合物是否是trt活性的调节剂，制备重组端粒酶以检测样品中trt基因产物的过程，检测包含人细胞的生物样品中d和至少一种端粒酶阳性人细胞的存在，以进行诊断
5. methods for screening for a therapeutic agent, for suppressing the polynucleotide sequence, for treating a non-steroidal cancer, for screening for binding of an agent specifically to a polynucleotide, and for determining whether a patient is at risk for developing or having a non-steroidal cancer, pharmaceutical composition, uses of a therapeutic agent, an antisense molecule or a cell that expresses and / or contains the antisense molecule, at least one of the immunogenic membrane proteins, fragments, derivatives or homologues thereof or from a cell containing and / or expressing at least one of the immunogenic membrane proteins or fragments, derivatives or homologues thereof and an agent or antibody, agent, and kit for identifying a patient at risk of developing or have non-steroidal cancer [P] . BRPI0414446A . 2006-11-14

机译：筛选治疗剂，抑制多核苷酸序列，治疗非甾体类癌症，筛选试剂特异性结合多核苷酸的方法以及确定患者是否处于发展或患有非糖尿病风险的方法类固醇癌，药物组合物，表达和/或含有反义分子的治疗剂，反义分子或细胞，免疫原性膜蛋白，其片段，衍生物或同源物中至少一种或来自含有和/或含有细胞的细胞的用途或表达至少一种免疫原性膜蛋白或其片段，衍生物或同系物以及一种试剂或抗体，试剂和试剂盒，用于鉴定有发生或患有非甾体癌风险的患者